Medtech experts say despite “schizophrenia,” the industry’s prognosis is good
The investment climate for the medtech industry has become more cautious, more focused on short-term results, and wary of increased government regulation. At the same time there are still plenty of opportunities for growth and success, a panel of CEOs and entrepreneurs said recently. The panel discussion was part of the MedTech Investing Conference, which […]